Regeneron Pharmaceuticals, Inc. which can be found using ticker (REGN) have now 23 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between the high target price and low target price is between 1050 and 650 suggesting an average Analsyt target price of $888.30. Now with the previous closing price of $745.57 this would imply there is now a potential upside of 19.1%. The day 50 moving average is $788.59 and the 200 day MA is $729.28. The market capitalization for the company is 82.24B. The current stock price for Microsoft Corporation is currently 744.35 USD
The potential market cap would be $97,981,456,625 based on the market consensus.
USD
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 20.37, revenue per share of 115.42 and a 10.44% return on assets.
